Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 13 of 13 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/15/19
End: 12/03/21
Due: 12/03/22
Phase: N/A
Priority: Normal
Start: 06/10/19
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 04/15/24
End: 12/31/27
Due: 12/31/28
Phase: N/A
Priority: Normal
Start: 03/31/16
End: 04/30/19
Due: 04/30/20
Phase: N/A
Priority: Normal
Start: 09/25/19
End: 12/31/34
Due: 12/31/35
Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CT041 Autologous CAR T-cell Injection
Phase: N/A
Priority: Normal
Start: 10/23/20
End: 06/30/38
Due: 06/30/39
Phase: N/A
Priority: Normal
Start: 08/14/19
End: 05/27/21
Due: 05/27/22
Phase: N/A
Priority: Normal
Start: 10/23/20
End: 09/01/35
Due: 09/01/36
Phase: N/A
Priority: Normal
Start: 07/11/23
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 10/08/23
End: 06/30/27
Due: 06/30/28
Phase: N/A
Priority: Normal
Start: 03/31/25
End: 06/30/40
Due: 06/30/41
Phase: N/A
Priority: Normal
Start: 10/31/24
End: 12/31/27
Due: 12/31/28
Phase: N/A
Priority: Normal
Start: 06/04/20
End: 09/28/23
Due: 09/28/24